Marketing leader behind growth of brands such as Cipladine, Maxirich, and Soak Shield takes on expanded responsibilities to drive portfolio growth and consumer engagement.
Diagnostic-guided healthcare platform strengthens leadership team to accelerate AI-driven diagnostics and consumer healthcare expansion
Growth driven by strong performance across Sugar Free, RiteBite Max Protein, Everyuth, Glucon-D and Nutralite portfolios
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
